Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 52 (3) , 716-723
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in miceToxicology, 2010
- Oxidative Stress as a Major Culprit in Kidney Disease in DiabetesDiabetes, 2008
- COQ2 NephropathyJournal of the American Society of Nephrology, 2007
- The antioxidant role of coenzyme QMitochondrion, 2007
- Modulation of Soluble Receptor for Advanced Glycation End Products by Angiotensin-Converting Enzyme-1 Inhibition in Diabetic NephropathyJournal of the American Society of Nephrology, 2005
- Chronic kidney disease in the general populationAdvances in Chronic Kidney Disease, 2005
- Utility of endogenous creatinine clearance as a measure of renal function in miceKidney International, 2004
- Biochemical Functions of Coenzyme Q10Journal of the American College of Nutrition, 2001
- Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damageNature, 2000
- Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.Proceedings of the National Academy of Sciences, 1996